These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

227 related items for PubMed ID: 32749248

  • 21. Efficacy of Four Scoring Systems in Predicting Intravenous Immunoglobulin Resistance in Children with Kawasaki Disease in a Children's Hospital in Beijing, North China.
    Song R, Yao W, Li X.
    J Pediatr; 2017 May; 184():120-124. PubMed ID: 28043682
    [Abstract] [Full Text] [Related]

  • 22. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M, Kobayashi T, Kaneko T, Ayusawa M, Fukazawa R, Fukushima N, Fuse S, Hamaoka K, Hirono K, Kato T, Mitani Y, Sato S, Shimoyama S, Shiono J, Suda K, Suzuki H, Maeda J, Waki K, The Z-score Project 2nd Stage Study Group, Kato H, Saji T, Yamagishi H, Ozeki A, Tomotsune M, Yoshida M, Akazawa Y, Aso K, Doi S, Fukasawa Y, Furuno K, Hayabuchi Y, Hayashi M, Honda T, Horita N, Ikeda K, Ishii M, Iwashima S, Kamada M, Kaneko M, Katyama H, Kawamura Y, Kitagawa A, Komori A, Kuraishi K, Masuda H, Matsuda S, Matsuzaki S, Mii S, Miyamoto T, Moritou Y, Motoki N, Nagumo K, Nakamura T, Nishihara E, Nomura Y, Ogata S, Ohashi H, Okumura K, Omori D, Sano T, Suganuma E, Takahashi T, Takatsuki S, Takeda A, Terai M, Toyono M, Watanabe K, Watanabe M, Yamamoto M, Yamamura K.
    JAMA Pediatr; 2018 May 07; 172(5):e180030. PubMed ID: 29507955
    [Abstract] [Full Text] [Related]

  • 23. Risk Factors for Resistance to Intravenous Immunoglobulin Treatment and Coronary Artery Abnormalities in a Chinese Pediatric Population With Kawasaki Disease: A Retrospective Cohort Study.
    Liu J, Huang Y, Chen C, Su D, Qin S, Pang Y.
    Front Pediatr; 2022 May 07; 10():812644. PubMed ID: 35515347
    [Abstract] [Full Text] [Related]

  • 24. Defining the risk of first intravenous immunoglobulin unresponsiveness in non-Asian patients with Kawasaki disease.
    Piram M, Darce Bello M, Tellier S, Di Filippo S, Boralevi F, Madhi F, Meinzer U, Cimaz R, Piedvache C, Koné-Paut I.
    Sci Rep; 2020 Feb 20; 10(1):3125. PubMed ID: 32080307
    [Abstract] [Full Text] [Related]

  • 25. Predictive factors of medium-giant coronary artery aneurysms in Kawasaki disease.
    Jiang S, Li M, Xu K, Xie Y, Liang P, Liu C, Su Q, Li B.
    Pediatr Res; 2024 Jan 20; 95(1):267-274. PubMed ID: 37670043
    [Abstract] [Full Text] [Related]

  • 26. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG, Gauvreau K, Hamaoka-Okamoto A, Tang A, Berry E, Tremoulet AH, Mahavadi VS, Baker A, deFerranti SD, Fulton DR, Burns JC, Newburger JW.
    J Am Heart Assoc; 2016 Sep 15; 5(9):. PubMed ID: 27633390
    [Abstract] [Full Text] [Related]

  • 27. Verification of "Japanese Scoring Systems" to Predict IVIG Resistance and Identification of Predictors for IVIG Resistance in Thai Children with Kawasaki Disease.
    Jarutach J, Roymanee S, Wongwaitaweewong K.
    Pediatr Cardiol; 2021 Dec 15; 42(8):1799-1804. PubMed ID: 34173835
    [Abstract] [Full Text] [Related]

  • 28. Early Appearance of Principal Symptoms of Kawasaki Disease is a Risk Factor for Intravenous Immunoglobulin Resistance.
    Tajima M, Shiozawa Y, Kagawa J.
    Pediatr Cardiol; 2015 Aug 15; 36(6):1159-65. PubMed ID: 25753685
    [Abstract] [Full Text] [Related]

  • 29. Risk scores for Kawasaki disease, a management tool developed by the KAWA-RACE cohort.
    Grasa CD, Fernández-Cooke E, Domínguez-Rodríguez S, Aracil-Santos J, Barrios Tascon A, Sánchez-Manubens J, Mercader B, Antón J, Nuñez E, Villalobos E, Bustillo M, Camacho M, Oltra Benavent M, Giralt G, Bello Naranjo AM, Rocandio B, Calvo C, Spanish group for the study of Kawasaki Disease (KAWA-RACE).
    Clin Rheumatol; 2022 Dec 15; 41(12):3759-3768. PubMed ID: 35939163
    [Abstract] [Full Text] [Related]

  • 30. Infliximab for intensification of primary therapy for patients with Kawasaki disease and coronary artery aneurysms at diagnosis.
    Miyata K, Bainto EV, Sun X, Jain S, Dummer KB, Burns JC, Tremoulet AH.
    Arch Dis Child; 2023 Oct 15; 108(10):833-838. PubMed ID: 37258054
    [Abstract] [Full Text] [Related]

  • 31. Determination of the Relationship Between Kobayashi, Sano, and Egami Criteria and Prevalence of Intravenous Immunoglobulin Resistance and Coronary Artery Aneurysm in Iranian Children with Kawasaki Disease.
    Shashaani N, Shiari R, Karimi A, Salehi S, Ghanaei R, Hassas Yeganeh M, Shiari S, Rahmani K, Javadi Parvaneh V.
    Open Access Rheumatol; 2020 Oct 15; 12():187-192. PubMed ID: 32943952
    [Abstract] [Full Text] [Related]

  • 32. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS, Raskin A, Gudausky TM, Kirkpatrick E.
    Am J Ther; 2016 Oct 15; 23(6):e1293-e1299. PubMed ID: 25611359
    [Abstract] [Full Text] [Related]

  • 33. Role of the Egami score to predict immunoglobulin resistance in Kawasaki disease among a Western Mediterranean population.
    Sánchez-Manubens J, Antón J, Bou R, Iglesias E, Calzada-Hernandez J, Borlan S, Gimenez-Roca C, Rivera J, Kawasaki Disease in Catalonia Working Group.
    Rheumatol Int; 2016 Jul 15; 36(7):905-10. PubMed ID: 27215220
    [Abstract] [Full Text] [Related]

  • 34. Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age.
    Song D, Yeo Y, Ha K, Jang G, Lee J, Lee K, Son C, Lee J.
    Eur J Pediatr; 2009 Nov 15; 168(11):1315-21. PubMed ID: 19159953
    [Abstract] [Full Text] [Related]

  • 35. Prediction Models for Intravenous Immunoglobulin Resistance in Kawasaki Disease: A Meta-analysis.
    Kuniyoshi Y, Tsujimoto Y, Banno M, Taito S, Ariie T, Takahashi N, Tokutake H, Takada T.
    Pediatrics; 2023 May 01; 151(5):. PubMed ID: 37092277
    [Abstract] [Full Text] [Related]

  • 36. A practical nomogram for predicting coronary thrombosis for Kawasaki disease patients with medium or large coronary artery aneurysm.
    Peng Y, Cheng Z, Yi Q.
    Clin Exp Med; 2023 Aug 01; 23(4):1317-1324. PubMed ID: 36151486
    [Abstract] [Full Text] [Related]

  • 37. Risk factors of immunoglobulin resistance and coronary complications in children with Kawasaki disease.
    Berdej-Szczot E, Małecka-Tendera E, Gawlik T, Firek-Pędras M, Szydłowski L, Gawlik A.
    Kardiol Pol; 2017 Aug 01; 75(3):261-266. PubMed ID: 27995598
    [Abstract] [Full Text] [Related]

  • 38. [Analysis of 2 diagnostic criteria of echocardiography for coronary artery aneurysm in Kawasaki disease].
    Liu WQ, Xia B, Fan W, Yu Z, Lin WL, Chen L, Wang C, Liu BN, Li J, Yang J.
    Zhonghua Er Ke Za Zhi; 2022 Jun 02; 60(6):588-593. PubMed ID: 35658368
    [Abstract] [Full Text] [Related]

  • 39. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R, Furuno K, Nanishi E, Onoyama S, Nagata H, Yamamura K, Sugitani Y, Kuraoka A, Mizuno Y, Sagawa K, Honjo S, Hara T, Ohga S.
    J Pediatr; 2020 Dec 02; 227():224-230.e3. PubMed ID: 32810506
    [Abstract] [Full Text] [Related]

  • 40. Prediction of intravenous immunoglobulin resistance in patients with Kawasaki disease according to the duration of illness prior to treatment.
    Ha KS, Lee J, Lee KC.
    Eur J Pediatr; 2020 Feb 02; 179(2):257-264. PubMed ID: 31713683
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.